Ascendis Pharma A/S (ASND)

204.08 -8.03 (-3.79%) USD  |  NASDAQ  |  Dec 17, 15:09
More

Ascendis Pharma CFO to Sales (TTM)

CFO to Sales (TTM) Chart

View CFO to Sales (TTM) for ASND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CFO to Sales (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CFO to Sales Definition

View CFO to Sales Definition
Start Trial

The Cash From Operations to Sales is a ratio that tells investors how capable a company is of generating cash from sales.

Read full definition.

CFO to Sales (TTM) Range, Past 5 Years

View CFO to Sales (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CFO to Sales (TTM) Benchmarks

View CFO to Sales (TTM) Benchmarks
Start Trial
Evaxion AS --
Novo Nordisk A/S Upgrade
DBV Technologies SA --
Cellectis SA Upgrade
Biodexa Pharmaceuticals Plc --